bioecon Member area
Technology · Services, governance & capital / Digital & IT

AI clinical-trial patient recruitment

Machine-learning software that scans structured and unstructured electronic health records to identify patients meeting a clinical trial's eligibility criteria and to score candidate trial sites on live population data, replacing the manual chart review that has made patient recruitment the biggest bottleneck before a trial can even begin.

Medicine & Pharmaceuticals Risk: low Pharma & biologics US Science: why it works → verified 2026-08-18 · 5 Sources (0 independent)

1 · What it gives

AI clinical-trial patient recruitment platforms scan structured and unstructured electronic health record data to identify patients meeting a trial’s eligibility criteria, replacing hours of manual chart review by clinical-research staff. Deep 6 AI optimizes site selection for clinical trials, letting sponsors base site choices on live population and screening data rather than historical site-performance metrics alone. TriNetX unveiled a conversational AI interface and enhanced API capabilities in January 2026, successfully reducing trial costs and timelines as part of platform enhancements designed to democratize clinical-research analytics. Antidote Technologies’ Antidote.me offers AI clinical-trial matching for physicians on an enterprise pay-for-performance model, connecting patients to research directly through referring clinicians. Mendel.ai’s software aims to save nurses time in pre-screening, and academic research on end-to-end AI-powered trial-recommendation systems (TrialMatchAI, published in Nature Communications 2026) explicitly frames patient recruitment as a major bottleneck calling for scalable, automated solutions — the problem this whole vendor category exists to solve. Paradigm Health’s AI-native solution increased screening capacity by 41% in an August 2026 partnership expanding clinical-trial access with Ochsner Health across the US Gulf South, and the company separately submitted a formal response to FDA’s Real-Time Clinical Trials Initiative RFI informed by biopharma sponsors and providers.

The key directions of AI clinical-trial patient recruitment are:

  1. EHR-based eligibility matching: scanning structured and unstructured patient records to automatically identify candidates meeting a trial’s specific eligibility criteria.
  2. Data-driven site selection: scoring candidate trial sites on live patient-population and screening data rather than relying on a site’s historical enrollment track record alone.
  3. Physician and patient-facing matching interfaces: conversational AI and referral tools that connect physicians and patients directly to relevant open trials.
  4. Screening-capacity expansion at health systems: deploying AI-native screening directly inside health-system workflows to expand the population that can be screened for trial eligibility.

Sectoral value chain#

[EHR data access & structuring] ──> [AI eligibility matching] ──> [Candidate patient shortlist]
                                                                    │
                                                        (Site-selection scoring)
                                                                    │
                    [Patient enrollment] <──── [Physician/patient outreach] <─── [Referring-clinician connection]

Value chain levels#

LevelDescriptionKey inputs/outputs
EHR data access & structuringAccessing and structuring a health system’s structured and unstructured patient record data for analysis.In: Raw EHR data.
Out: Structured, analyzable patient data.
AI eligibility matchingApplying AI models to identify patients matching a specific trial’s eligibility criteria.In: Structured patient data, trial eligibility criteria.
Out: Matched candidate list.
Candidate patient shortlistCompiling the matched candidates into a shortlist for clinical-research staff review.In: Matched candidate list.
Out: Reviewed candidate shortlist.
Site-selection scoringScoring candidate trial sites on live population and screening data to inform sponsor site selection.In: Aggregated population/screening data.
Out: Site-selection score.
Referring-clinician connectionConnecting a matched patient to the trial through their referring physician.In: Reviewed candidate shortlist.
Out: Physician referral to trial.
Patient enrollmentCompleting the enrollment process for the referred, eligible patient.In: Physician referral to trial.
Out: Enrolled trial participant.

Cross-cutting technologies of the sector:

  • AI patient-trial matching: machine-learning software that scans structured and unstructured EHR data to identify patients meeting a trial’s eligibility criteria, replacing manual chart review.
  • Real-time trial site-selection analytics: analytics that score candidate trial sites on live patient-population and screening data, letting a sponsor pick sites likely to enroll quickly.

2 · What it replaces 0 · matched by industry

No graded substitution linked yet.

3 · How to implement 6 steps

  1. 1
    EHR data access and structuring
    The platform accesses and structures a health system’s structured and unstructured patient record data for AI analysis.
  2. 2
    AI eligibility matchingData, software & automation
    AI models identify patients matching a specific trial’s eligibility criteria from the structured data.
    Who can do this step matched automatically
    ✓ GMP 7,500 MT/ industrial scale
    “Even the administrative processes are green, where IGL has adopted the latest SAP ERP (S/4 HANA 2023 version), Salesforce CRM, Industrial IOT & other tech solutions to drive …”
    163,050 tonnes
    “As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”
    Metso Finland
    “With completely new and redesigned software,”
    ✓ GMP industrial scale
    “The two parties will conduct extensive cooperationin the fields of digital agriculture, intelligent breeding and planting,precision feeding, manure treatment, animal disease …”
    MIRAI Japan
    industrial scale
    “It also runs IoT/“SensorCorpus” software for monitoring/optimization, and its cultivation tech has been described as LED/water/airflow method optimization (e.g., “heavy lettuce”); …”
  3. 3
    Candidate patient shortlist
    Matched candidates are compiled into a shortlist for clinical-research staff review.
  4. 4
    Site-selection scoring
    Candidate trial sites are scored on live population and screening data to inform sponsor site-selection decisions.
  5. 5
    Referring-clinician connection
    A matched, eligible patient is connected to the trial through their referring physician.
  6. 6
    Patient enrollment
    The enrollment process is completed for the referred, eligible patient, closing the loop from EHR data to enrolled participant.

4 · Who delivers

Matched suppliers (matched automatically)

FreseniusGermanyProduceractive
Scholar RockUnited StatesProduceractive
MindrayChinaProduceractive
Altos LabsUnited StatesResearch / RTOactive
BiohavenUnited StatesResearch / RTOactive
Kirin HoldingsJapanProduceractive
Recursion PharmaceuticalsUnited StatesResearch / RTOactive
GenmabDenmarkProduceractive
Boston ScientificUnited StatesProduceractive
Insilico MedicineCayman IslandsProduceractive
MeijiJapanResearch / RTOactive

In the services and supply catalogue 2 · paid service

LIMS / MES & lab informatics · Process modelling & simulation

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Deep 6 AI🇺🇸 USASite Selection platformLive population/screening-data-based site scoringcommercial
TriNetX🇺🇸 USAConversational AI interface, enhanced APIsReduced trial costs and timelines (2026)commercial
Antidote🇺🇸 USAAntidote.mePhysician-facing AI matching, pay-for-performancecommercial
Mendel.ai🇺🇸 USAMendel.ai pre-screening softwareNurse pre-screening time savingscommercial
Paradigm Health🇺🇸 USAAI-native screening platform41% screening-capacity increase at Ochsner Healthcommercial

5 · Rules & route to market

United States

The United States hosts the leading AI patient-recruitment vendors, several with direct 2026 health-system deployments and platform enhancements.

Deep 6 AI’s site-selection optimization, TriNetX’s conversational AI, Paradigm Health’s 41% screening-capacity gain#

  • Deep 6 AI: optimizes clinical-trial site selection using live population and screening data rather than historical site performance alone.
  • TriNetX: unveiled a conversational AI interface and enhanced API capabilities in January 2026, reducing trial costs and timelines as part of a broader effort to democratize clinical-research analytics.
  • Antidote Technologies: its Antidote.me platform offers AI clinical-trial matching for physicians on an enterprise pay-for-performance model.
  • Mendel.ai: its software aims to save nurses time in pre-screening, applying AI directly to the recruitment bottleneck that academic research has identified as the field’s central constraint.
  • Paradigm Health: an August 2026 partnership with Ochsner Health increased screening capacity by 41% across the US Gulf South, and the company formally responded to FDA’s Real-Time Clinical Trials Initiative RFI.

European Union

No EU-headquartered vendor cleared the confirmation bar on this screen distinct from the US-headquartered platforms already tabled; European trial sponsors and health systems are served by the same global vendors listed above.

Served by the same global platforms rather than a distinct EU-headquartered specialist#

  • EU deployment of global platforms: the vendors tabled above serve EU clinical-trial sponsors and health systems directly rather than through a confirmed distinct EU-headquartered competitor.
  • No distinct EU-headquartered vendor confirmed: this screen did not surface an EU-headquartered AI patient-recruitment specialist distinct from the platforms already listed.

China

China is covered qualitatively rather than by a live-screened Chinese vendor: candidate Chinese AI patient-recruitment firms searched during this screen returned only generic market-research reports and academic commentary, not a confirmed named vendor, so no Chinese company is tabled below.

No confirmed named domestic vendor; market-research coverage describes the category rather than naming a leader#

  • Market coverage without a named leader: Chinese-language sources describe the AI clinical-trial patient-recruitment market’s growth and trends extensively, but this screen did not surface a specific China-headquartered vendor confirmed by name in a live 2026 source.
  • Domestic gap: no China-headquartered AI patient-recruitment platform confirmed by name was found during this screen.

6 · Money: tenders & grants

7 · Tech stack & innovations

The AI clinical-trial patient recruitment technology stack combines EHR-scale data access with an increasingly conversational and health-system-embedded AI layer:

  1. Large-scale EHR data matching:
    • Deep 6 AI and Mendel.ai apply AI directly to structured and unstructured EHR data to identify eligible patients without manual chart review.
  2. Conversational AI and API expansion:
    • TriNetX’s January 2026 conversational AI interface and expanded APIs show the category moving toward more accessible, integration-friendly tooling.
  3. Health-system-embedded screening deployment:
    • Paradigm Health’s direct partnership with a regional health system (Ochsner Health) demonstrates AI screening deployed inside clinical workflows rather than as a standalone research tool, delivering a measured 41% capacity gain.

Sources 5 · 0 independent · 5 producer sites

Producers' own sites 5

  1. Deep6ai producer checked 2026-05-25 · link not kept
  2. Trinetx producer checked 2026-07-15 · link not kept
  3. Antidote producer checked 2026-04-24 · link not kept
  4. Mendel ai producer checked 2026-05-25 · link not kept
  5. Paradigm health producer checked 2026-08-12 · link not kept